 Kathleen Woulfe
Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardium | 10 | 2024 | 932 | 1.290 |
Why?
| | Myocytes, Cardiac | 14 | 2023 | 544 | 1.230 |
Why?
| | Myofibrils | 6 | 2024 | 49 | 1.080 |
Why?
| | Calcium | 5 | 2024 | 1190 | 1.030 |
Why?
| | Heart Ventricles | 5 | 2022 | 754 | 0.990 |
Why?
| | Troponin I | 2 | 2023 | 73 | 0.780 |
Why?
| | Cytoskeleton | 1 | 2023 | 198 | 0.730 |
Why?
| | Heart Failure | 7 | 2024 | 2329 | 0.710 |
Why?
| | Heart | 4 | 2024 | 626 | 0.670 |
Why?
| | Microtubules | 1 | 2023 | 287 | 0.670 |
Why?
| | Phosphorylation | 4 | 2023 | 1707 | 0.650 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2020 | 56 | 0.630 |
Why?
| | Calcium-Binding Proteins | 1 | 2021 | 222 | 0.610 |
Why?
| | Isoproterenol | 2 | 2021 | 96 | 0.580 |
Why?
| | Ventricular Remodeling | 5 | 2021 | 277 | 0.550 |
Why?
| | Cardiomyopathy, Dilated | 2 | 2021 | 356 | 0.530 |
Why?
| | Geriatrics | 1 | 2018 | 95 | 0.520 |
Why?
| | Arrhythmias, Cardiac | 2 | 2022 | 355 | 0.490 |
Why?
| | Death, Sudden, Cardiac | 1 | 2018 | 231 | 0.480 |
Why?
| | Ventricular Function, Left | 2 | 2022 | 539 | 0.470 |
Why?
| | Glycogen Synthase Kinase 3 | 3 | 2010 | 82 | 0.440 |
Why?
| | Heart Rate | 1 | 2018 | 859 | 0.410 |
Why?
| | Cardiomegaly | 3 | 2024 | 174 | 0.410 |
Why?
| | MicroRNAs | 1 | 2016 | 689 | 0.310 |
Why?
| | Pediatrics | 1 | 2018 | 1121 | 0.310 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 2 | 2021 | 72 | 0.300 |
Why?
| | Carrier Proteins | 2 | 2023 | 733 | 0.290 |
Why?
| | Sarcomeres | 3 | 2023 | 98 | 0.270 |
Why?
| | Animals | 23 | 2024 | 38141 | 0.260 |
Why?
| | Rats, Sprague-Dawley | 4 | 2021 | 2526 | 0.260 |
Why?
| | Cardiomyopathies | 2 | 2020 | 335 | 0.240 |
Why?
| | Cardiomyopathy, Hypertrophic | 2 | 2021 | 144 | 0.210 |
Why?
| | Distal Myopathies | 1 | 2024 | 12 | 0.210 |
Why?
| | Protein Processing, Post-Translational | 2 | 2024 | 468 | 0.210 |
Why?
| | Gene Expression Profiling | 3 | 2021 | 1769 | 0.200 |
Why?
| | Boidae | 1 | 2024 | 31 | 0.200 |
Why?
| | Myocardial Contraction | 2 | 2023 | 291 | 0.200 |
Why?
| | Proline | 1 | 2024 | 82 | 0.200 |
Why?
| | Myocardial Infarction | 2 | 2011 | 1216 | 0.190 |
Why?
| | Amino Acid Substitution | 1 | 2024 | 303 | 0.190 |
Why?
| | Rats | 6 | 2022 | 5581 | 0.180 |
Why?
| | Age Factors | 3 | 2021 | 3340 | 0.180 |
Why?
| | Thiazepines | 1 | 2021 | 6 | 0.170 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2021 | 32 | 0.170 |
Why?
| | Serum Response Factor | 1 | 2021 | 33 | 0.170 |
Why?
| | Heart Murmurs | 1 | 2021 | 14 | 0.170 |
Why?
| | Estrogens | 1 | 2024 | 364 | 0.170 |
Why?
| | Lysine | 2 | 2020 | 272 | 0.160 |
Why?
| | Adrenergic beta-Agonists | 1 | 2021 | 93 | 0.160 |
Why?
| | Tropomyosin | 1 | 2020 | 10 | 0.160 |
Why?
| | Muscle Proteins | 1 | 2022 | 242 | 0.160 |
Why?
| | Rats, Inbred Dahl | 1 | 2020 | 9 | 0.160 |
Why?
| | Troponin T | 1 | 2020 | 63 | 0.160 |
Why?
| | RNA, Long Noncoding | 1 | 2022 | 172 | 0.160 |
Why?
| | Alternative Splicing | 1 | 2022 | 247 | 0.150 |
Why?
| | Mice | 13 | 2024 | 18338 | 0.150 |
Why?
| | Succinic Acid | 1 | 2019 | 46 | 0.150 |
Why?
| | Female | 12 | 2024 | 78763 | 0.150 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 672 | 0.150 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2021 | 218 | 0.150 |
Why?
| | Acetylation | 1 | 2020 | 250 | 0.150 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 294 | 0.140 |
Why?
| | Cell Line | 2 | 2021 | 2823 | 0.140 |
Why?
| | Flecainide | 1 | 2018 | 8 | 0.140 |
Why?
| | HEK293 Cells | 1 | 2021 | 743 | 0.140 |
Why?
| | Cell Culture Techniques | 1 | 2021 | 373 | 0.140 |
Why?
| | Guinea Pigs | 1 | 2018 | 160 | 0.140 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 272 | 0.130 |
Why?
| | Myocardial Ischemia | 1 | 2019 | 287 | 0.130 |
Why?
| | Gene Deletion | 2 | 2010 | 392 | 0.130 |
Why?
| | Mitochondrial Proteins | 1 | 2019 | 262 | 0.130 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2018 | 144 | 0.130 |
Why?
| | RNA-Binding Proteins | 1 | 2021 | 461 | 0.130 |
Why?
| | Pyrroles | 2 | 2009 | 213 | 0.130 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2016 | 16 | 0.130 |
Why?
| | Humans | 18 | 2024 | 145491 | 0.130 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2016 | 55 | 0.120 |
Why?
| | Galectin 3 | 1 | 2016 | 20 | 0.120 |
Why?
| | Extracellular Matrix | 1 | 2021 | 562 | 0.120 |
Why?
| | Myosin Heavy Chains | 2 | 2024 | 183 | 0.120 |
Why?
| | Gene Expression | 1 | 2021 | 1478 | 0.120 |
Why?
| | Statistics as Topic | 1 | 2016 | 284 | 0.120 |
Why?
| | Signal Transduction | 6 | 2021 | 5202 | 0.110 |
Why?
| | Male | 10 | 2024 | 72817 | 0.110 |
Why?
| | Action Potentials | 1 | 2018 | 502 | 0.110 |
Why?
| | Disease Models, Animal | 3 | 2022 | 4559 | 0.110 |
Why?
| | Oxidation-Reduction | 1 | 2018 | 1080 | 0.110 |
Why?
| | Cell Differentiation | 2 | 2021 | 2045 | 0.110 |
Why?
| | Indoles | 2 | 2009 | 508 | 0.100 |
Why?
| | Fibrosis | 1 | 2016 | 551 | 0.100 |
Why?
| | Interleukin-1 | 1 | 2016 | 961 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2022 | 456 | 0.090 |
Why?
| | Aging | 2 | 2021 | 1940 | 0.090 |
Why?
| | Group IV Phospholipases A2 | 1 | 2011 | 46 | 0.090 |
Why?
| | Mice, Knockout | 3 | 2022 | 3125 | 0.080 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2011 | 139 | 0.080 |
Why?
| | Wnt Proteins | 2 | 2007 | 133 | 0.080 |
Why?
| | Mutation | 1 | 2020 | 4093 | 0.070 |
Why?
| | Myoblasts, Cardiac | 1 | 2008 | 3 | 0.070 |
Why?
| | Exons | 1 | 2010 | 363 | 0.070 |
Why?
| | Vasoconstriction | 1 | 2010 | 216 | 0.070 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 443 | 0.070 |
Why?
| | Cell Division | 1 | 2010 | 753 | 0.070 |
Why?
| | Receptor Cross-Talk | 1 | 2007 | 21 | 0.070 |
Why?
| | Frizzled Receptors | 1 | 2007 | 25 | 0.060 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2009 | 191 | 0.060 |
Why?
| | Aorta, Thoracic | 1 | 2010 | 286 | 0.060 |
Why?
| | Mice, Inbred C57BL | 3 | 2021 | 5989 | 0.060 |
Why?
| | Time Factors | 1 | 2018 | 7171 | 0.060 |
Why?
| | Sex Factors | 2 | 2024 | 2110 | 0.060 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2007 | 123 | 0.060 |
Why?
| | Protein Binding | 2 | 2023 | 2250 | 0.060 |
Why?
| | Promoter Regions, Genetic | 1 | 2010 | 1247 | 0.060 |
Why?
| | Protein Kinase Inhibitors | 2 | 2009 | 980 | 0.060 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2007 | 231 | 0.060 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2023 | 431 | 0.050 |
Why?
| | Cardiac Myosins | 1 | 2024 | 37 | 0.050 |
Why?
| | Postprandial Period | 1 | 2024 | 114 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2021 | 4127 | 0.050 |
Why?
| | Stroke Volume | 2 | 2022 | 654 | 0.050 |
Why?
| | Proteomics | 2 | 2021 | 1191 | 0.050 |
Why?
| | Myosins | 1 | 2023 | 133 | 0.050 |
Why?
| | Tyrosine | 1 | 2023 | 219 | 0.050 |
Why?
| | Histone Deacetylase 6 | 1 | 2022 | 17 | 0.050 |
Why?
| | Connectin | 1 | 2022 | 42 | 0.050 |
Why?
| | Catecholamines | 1 | 2022 | 88 | 0.050 |
Why?
| | Mutation, Missense | 1 | 2024 | 338 | 0.040 |
Why?
| | Cats | 1 | 2022 | 228 | 0.040 |
Why?
| | RNA Splicing Factors | 1 | 2022 | 66 | 0.040 |
Why?
| | Rats, Transgenic | 1 | 2021 | 19 | 0.040 |
Why?
| | Rats, Inbred BN | 1 | 2021 | 55 | 0.040 |
Why?
| | Adrenergic Agents | 1 | 2021 | 7 | 0.040 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2022 | 324 | 0.040 |
Why?
| | Muscle Contraction | 1 | 2024 | 430 | 0.040 |
Why?
| | Phenylephrine | 1 | 2021 | 74 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2008 | 2499 | 0.040 |
Why?
| | Protein Isoforms | 1 | 2022 | 396 | 0.040 |
Why?
| | Culture Media | 1 | 2021 | 163 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2024 | 570 | 0.040 |
Why?
| | Diastole | 1 | 2020 | 146 | 0.040 |
Why?
| | Acylation | 1 | 2019 | 30 | 0.040 |
Why?
| | Middle Aged | 3 | 2019 | 36176 | 0.040 |
Why?
| | Longevity | 1 | 2021 | 175 | 0.040 |
Why?
| | Methylation | 1 | 2019 | 242 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2024 | 2189 | 0.040 |
Why?
| | Drosophila Proteins | 1 | 2020 | 213 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2024 | 779 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2024 | 932 | 0.030 |
Why?
| | Actins | 1 | 2020 | 421 | 0.030 |
Why?
| | Models, Biological | 2 | 2021 | 1815 | 0.030 |
Why?
| | Glycogen Synthase Kinase 3 beta | 2 | 2008 | 73 | 0.030 |
Why?
| | Fatty Acids | 1 | 2021 | 459 | 0.030 |
Why?
| | Child | 1 | 2016 | 22680 | 0.030 |
Why?
| | Tissue Donors | 1 | 2019 | 421 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2007 | 2207 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2021 | 907 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2024 | 1794 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3424 | 0.020 |
Why?
| | Misoprostol | 1 | 2011 | 16 | 0.020 |
Why?
| | Telemetry | 1 | 2011 | 40 | 0.020 |
Why?
| | Consciousness | 1 | 2011 | 35 | 0.020 |
Why?
| | Intracellular Space | 1 | 2011 | 64 | 0.020 |
Why?
| | Neutrophil Infiltration | 1 | 2011 | 104 | 0.020 |
Why?
| | Dinoprostone | 1 | 2011 | 180 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 174 | 0.020 |
Why?
| | Cell Separation | 1 | 2011 | 304 | 0.020 |
Why?
| | Cell Death | 1 | 2011 | 383 | 0.020 |
Why?
| | Inhibitory Concentration 50 | 1 | 2009 | 90 | 0.020 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2009 | 74 | 0.020 |
Why?
| | Cell Size | 1 | 2008 | 92 | 0.020 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2009 | 138 | 0.020 |
Why?
| | Capillaries | 1 | 2009 | 120 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2008 | 234 | 0.020 |
Why?
| | Axin Protein | 1 | 2007 | 18 | 0.020 |
Why?
| | beta-Arrestins | 1 | 2007 | 15 | 0.020 |
Why?
| | Arrestins | 1 | 2007 | 14 | 0.020 |
Why?
| | TCF Transcription Factors | 1 | 2007 | 19 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2009 | 172 | 0.020 |
Why?
| | Gastrointestinal Stromal Tumors | 1 | 2007 | 41 | 0.020 |
Why?
| | Endocytosis | 1 | 2007 | 168 | 0.020 |
Why?
| | Multicenter Studies as Topic | 1 | 2007 | 411 | 0.010 |
Why?
| | Echocardiography | 1 | 2009 | 648 | 0.010 |
Why?
| | Cell Survival | 1 | 2009 | 1094 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2007 | 762 | 0.010 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2009 | 452 | 0.010 |
Why?
| | Biopsy | 1 | 2009 | 1081 | 0.010 |
Why?
| | beta Catenin | 1 | 2007 | 253 | 0.010 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2007 | 426 | 0.010 |
Why?
| | Repressor Proteins | 1 | 2007 | 430 | 0.010 |
Why?
| | Proteins | 1 | 2009 | 1020 | 0.010 |
Why?
| | Mitochondria | 1 | 2009 | 990 | 0.010 |
Why?
| | Blood Pressure | 1 | 2007 | 1782 | 0.010 |
Why?
| | Transcription Factors | 1 | 2009 | 1733 | 0.010 |
Why?
| | Risk Factors | 1 | 2011 | 10874 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2007 | 17269 | 0.000 |
Why?
|
|
Woulfe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|